Elie Offroy-Besserer

Sherbrooke, QC J1H5N4, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Improved brain penetration of neurotensin(8-13) via blood-brain barrier shuttle conjugation underlies strong analgesia.

Improved brain penetration of neurotensin(8-13) via blood-brain barrier shuttle conjugation underlies strong analgesia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 05, 2026

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 02, 2025

Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point Mutation.

Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point Mutation.

Journal: ACS pharmacology & translational science
Published: October 23, 2025

A neurotensin receptor type 1-derived pepducin acts as a biased allosteric modulator to regulate target receptor function.

A neurotensin receptor type 1-derived pepducin acts as a biased allosteric modulator to regulate target receptor function.

Journal: Acta pharmaceutica Sinica. B
Published: August 01, 2025

Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.

Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.

Journal: CNS drugs
Published: February 16, 2025

A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor.

A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor.

Journal: Pharmacological research
Published: August 23, 2024

Structure-based design of macrocyclic peptides to generate functional antibodies against G protein-coupled receptors.

Structure-based design of macrocyclic peptides to generate functional antibodies against G protein-coupled receptors.

Journal: Nature communications
Published: August 16, 2024

Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice.

Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 27, 2024

Discovery of a CCR2-targeting pepducin therapy for chronic pain.

Discovery of a CCR2-targeting pepducin therapy for chronic pain.

Journal: Pharmacological research
Published: January 26, 2024

Size-Reduced Macrocyclic Analogues of [Pyr1]-apelin-13 Showing Negative Gα12 Bias Still Produce Prolonged Cardiac Effects.

Size-Reduced Macrocyclic Analogues of [Pyr1]-apelin-13 Showing Negative Gα12 Bias Still Produce Prolonged Cardiac Effects.

Journal: Journal of medicinal chemistry
Published: January 04, 2022

Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation.

Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation.

Journal: International journal of molecular sciences
Published: November 08, 2021

Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR.

Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR.

Journal: Biomolecules
Published: October 29, 2020
Showing 1-12 of 37

Last Updated: 09/26/2026